![Kyle Carver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kyle Carver
Directeur Financier/CFO chez
EVOMMUNE, INC.
Fortune : 801 852 $ au 30/06/2026
Profil
Kyle Carver worked at Kadmon Holdings, Inc. from 2014 to 2022, serving as Chief Accounting Officer & Controller from 2018 to 2022.
Mr. Carver completed undergraduate studies at Villanova University and earned an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOMMUNE, INC. 0,17 % | 08/07/2026 | 60 335 ( 0,17 % ) | 801 852 $ | 30/06/2026 |
Postes actifs de Kyle Carver
| Sociétés | Poste | Début |
|---|---|---|
| EVOMMUNE, INC. | Directeur Financier/CFO | 01/03/2022 |
Anciens postes connus de Kyle Carver
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Comptroller/Controller/Auditor | 01/03/2022 |
Formation de Kyle Carver
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
